CUSIP N51517105SHSQ3 2025
20 filings · latest Oct 22, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Shay Capital LLC | 2.55M | $3.98M |
| 2 | Redmile Group, LLC | 2.07M | $3.24M |
| 3 | Bml Capital Management, LLC | 1.97M | $3.07M |
| 4 | Sanofi | 1.92M | $2.99M |
| 5 | Merck & Co., Inc. | 1.15M | $1.79M |
| 6 | Gts Securities LLC | 200.0K | $312.0K |
| 7 | Rangeley Capital, LLC | 165.0K | $257.4K |
| 8 | Pnc Financial Services Group, Inc. | 65.0K | $101.4K |
| 9 | Citadel Advisors LLC |
| 4 | Sep 26, 2025 | Shay Capital LLC | 13G | 11.0% | 2.60M | SEC |
| 5 | Sep 23, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | — | — | SEC |
| 6 | Sep 18, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | 9.0% | — | SEC |
| 7 | Mar 3, 2025 | Bml Investment Partners, L.P. | 13G | 7.4% | 1.96M | SEC |
| 8 | Mar 7, 2024 | Novo Holdings A/S | 13D/A | — | — | SEC |
| 9 | Feb 14, 2024 | Redmile Group, LLC | 13G/A | 7.9% | 2.07M | SEC |
| 10 | Nov 9, 2023 | Novo Holdings A/S | 13D/A | 7.1% | 1.88M | SEC |
See the full Schedule 13D/13G history for Lava Therapeutics NV.
Unlock full history| 53.3K |
| $83.2K |
| 10 | Royal Bank Of Canada | 44.3K | $69.0K |